跳至主要内容
临床试验/NCT05988047
NCT05988047已完成不适用

Analysis of CMTM6 Expression in Patients With Acute Myeloid Leukemia

University of Freiburg1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2020年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
150
试验地点
1
主要终点
T cell activation (FC)

研究概览

简要总结

In this study, we aim to investigate the expression of CKLF like MARVEL transmembrane domain containing 6 (CMTM6) in leukemia cells of patients with acute myeloid leukemia (AML). We will use peripheral blood samples and assess CMTM6 expression by flow cytometry and Western Blot.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age ≥ 18 years
  • primary diagnosis of acute myeloid leukemia
  • diagnosis results available
  • written informed consent
  • ability to understand the nature of the study and the study related procedures and to comply with them

排除标准

  • age < 18 years
  • lack of informed consent

结局指标

主要结局

T cell activation (FC)

时间窗: At primary diagnosis

T cell activation and cytokine production will be measured by flow cytometry

CMTM6 expression (FC)

时间窗: At primary diagnosis

CMTM6 expression on blasts/monocytes will be measured by flow cytometry

次要结局

  • CMTM6 expression (WB)(At primary diagnosis)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert Zeiser

Professor

University of Freiburg

研究点 (1)

Loading locations...

相似试验

Analysis of CMTM6 Expression in Patients With Acute... | 临床试验